Literature DB >> 12802616

MR imaging-guided axillary node biopsy for breast cancer: initial findings.

Takuji Yamagami1, Sachiko Yuen, Kiyoshi Sawai, Tsunehiko Nishimura.   

Abstract

The aim of this study was to evaluate the usefulness and feasibility of preoperative sentinel node needle biopsy of the breast under guidance of open MR imaging, a method that we developed. Nine patients with breast cancer in whom the axillary lymph nodes were not palpable underwent preoperative sentinel node needle biopsy under real-time MR imaging guidance. The sentinel nodes were identified before the biopsy using CT and MR imaging. Diagnostic ability of this method was compared with that of the operative diagnosis. Sentinel nodes were correctly identified in all 9 patients. The MR imaging-guided sentinel node needle biopsy was performed for all of the 9 patients, and, in 7 (77.8%) of the 9, a specimen sufficient for pathologic evaluation was obtained; and in 6, whether malignancy existed was precisely diagnosed. No serious complications were noted. This experience indicates the possibility of a precise diagnosis of whether the sentinel node in breast cancer is benign or malignant without surgery.

Entities:  

Mesh:

Year:  2003        PMID: 12802616     DOI: 10.1007/s00330-003-1938-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  34 in total

1.  Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement.

Authors:  Sven C A Michel; Thomas M Keller; Johannes M Fröhlich; Daniel Fink; Rosmarie Caduff; Burkhardt Seifert; Borut Marincek; Rahel A Kubik-Huch
Journal:  Radiology       Date:  2002-11       Impact factor: 11.105

2.  Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI.

Authors:  K A Kvistad; J Rydland; H B Smethurst; S Lundgren; H E Fjøsne; O Haraldseth
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

3.  Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care.

Authors:  K M McMasters; A E Giuliano; M I Ross; D S Reintgen; K K Hunt; D R Byrd; V S Klimberg; P W Whitworth; L C Tafra; M J Edwards
Journal:  N Engl J Med       Date:  1998-10-01       Impact factor: 91.245

4.  Sentinel-lymph-node biopsy in breast cancer.

Authors:  G Querci della Rovere; P A Bird
Journal:  Lancet       Date:  1998-08-08       Impact factor: 79.321

5.  Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer.

Authors:  A Y de Kanter; C H van Eijck; A N van Geel; R H Kruijt; S C Henzen; M A Paul; A M Eggermont; T Wiggers
Journal:  Br J Surg       Date:  1999-11       Impact factor: 6.939

6.  Mammary lymphoscintigraphy with various radiopharmaceuticals in breast cancer.

Authors:  S Imoto; K Murakami; H Ikeda; H Fukukita; N Moriyama
Journal:  Ann Nucl Med       Date:  1999-10       Impact factor: 2.668

7.  Axillary lymph nodes: mammographic, pathologic, and clinical correlation.

Authors:  R Walsh; P J Kornguth; M S Soo; R Bentley; D M DeLong
Journal:  AJR Am J Roentgenol       Date:  1997-01       Impact factor: 3.959

8.  Sentinel node biopsy in breast cancer.

Authors:  J M Barnwell; M A Arredondo; D Kollmorgen; J F Gibbs; D Lamonica; W Carson; P Zhang; J Winston; S B Edge
Journal:  Ann Surg Oncol       Date:  1998-03       Impact factor: 5.344

9.  Gamma probe and ultrasonographically-guided fine-needle aspiration biopsy of sentinel lymph nodes in breast cancer patients.

Authors:  K Motomura; H Inaji; Y Komoike; T Kasugai; S Nagumo; Y Hasegawa; S Noguchi; H Koyama
Journal:  Eur J Surg Oncol       Date:  2001-03       Impact factor: 4.424

10.  Evaluation of axillary status in breast cancer. CT-based determination of sentinel lymph node size.

Authors:  S Yuen; K Sawai; Y Ushijima; C Okuyama; T Yamagami; K Yamada; T Nishimura
Journal:  Acta Radiol       Date:  2002-11       Impact factor: 1.701

View more
  2 in total

1.  Percutaneous removal of sentinel lymph nodes in a swine model using a breast lesion excision system and contrast-enhanced ultrasound.

Authors:  Ali R Sever; Philippa Mills; Jean-Marc Hyvelin; Jennifer Weeks; Hatice Gumus; David Fish; Willem Mali; Susan E Jones; Peter A Jones; Haresh Devalia
Journal:  Eur Radiol       Date:  2011-10-07       Impact factor: 5.315

2.  Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging--initial findings.

Authors:  Tadeusz W Stadnik; Hendrik Everaert; Smitha Makkat; Robert Sacré; Jan Lamote; Claire Bourgain
Journal:  Eur Radiol       Date:  2006-05-03       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.